Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.740
0.00 (0.00%)
Apr 2, 2026, 4:00 PM EDT - Market closed

Daré Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2528273170168
Market Cap Growth
-1.81%1.59%-12.18%-56.10%-58.06%201.20%
Enterprise Value
3.283.4312.221.3735.83116.21
Last Close Price
1.741.933.123.719.9624.00
PE Ratio
--1.61-6.50-0.89-2.24-3.17
PS Ratio
24.5926.772774.4511.017.04-
PB Ratio
8.889.70-4.52-6.126.344.33
P/TBV Ratio
6.847.59-4.41-5.356.323.16
P/FCF Ratio
--2.695.54-0.78-3.88-5.83
P/OCF Ratio
--2.794.96-0.80-3.89-5.84
EV/Sales Ratio
3.183.331247.087.613.58-
EV/EBITDA Ratio
--0.29-0.52-0.69-1.14-2.98
EV/EBIT Ratio
--0.25-0.52-0.69-1.14-2.97
EV/FCF Ratio
--0.332.49-0.54-1.97-4.04
Debt / Equity Ratio
0.200.20-0.13-0.190.010
Debt / EBITDA Ratio
-0.22-0.22-0.06-0.04-0.02-0.01
Debt / FCF Ratio
-0.26-0.260.27-0.04-0.03-0.01
Net Debt / Equity Ratio
-7.76-7.762.391.80-3.08-1.33
Net Debt / EBITDA Ratio
1.851.850.620.291.091.32
Net Debt / FCF Ratio
2.152.15-2.940.231.881.79
Asset Turnover
0.040.040.000.090.200
Quick Ratio
1.041.040.730.561.153.29
Current Ratio
1.141.140.850.861.363.44
Return on Equity (ROE)
845.53%845.53%73.30%-994.69%-124.12%-205.82%
Return on Assets (ROA)
-49.66%-49.66%-108.11%-95.04%-63.00%-123.33%
Return on Invested Capital (ROIC)
-350.12%-350.12%-728.78%-8073.96%1288.55%2998.30%
Return on Capital Employed (ROCE)
-292.17%-292.17%-3636.33%-475.84%-120.81%-197.09%
Earnings Yield
-52.89%-62.18%-15.38%-111.86%-44.58%-31.50%
FCF Yield
-40.54%-37.24%18.05%-127.75%-25.78%-17.14%
Buyback Yield / Dilution
-31.55%-31.55%-16.80%-3.23%-38.29%-103.23%
Total Shareholder Return
-31.55%-31.55%-16.80%-3.23%-38.29%-103.23%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q